Molecular biomarkers in stroke diagnosis and prognosis
نویسندگان
چکیده
منابع مشابه
P154: Role of Exosomes as Novel Biomarkers in Diagnosis and Prognosis of Glioblastoma
Glioblastoma multiform(GBM) is the most prevalent primary brain tumor. Exosomes are extracellular vehicles for exchanging information between various cell types including cancer and normal cells. Exosomes are indicative of pathophysiological conditions of brain tumors that could be used in diagnosis and prognosis of GBM. In tumors, exosomes could carry various molecules like several miRNAs and ...
متن کاملHeart Failure: Biomarkers of Diagnosis and Prognosis
The natriuretic peptides (NP), including the precursor N-terminal proBNP (NT-pro-BNP) of biologically active B-type natriuretic peptide (BNP) represent the current standard for identifying Heart Failure. In addition, the troponins serve to help identify Heart Failure patients at high risk for adverse outcomes. For nearly the last decade, emergency physicians have used these biomarkers to diagno...
متن کاملMolecular Biomarkers & Diagnosis
Nasopharyngeal carcinoma (NPC) is a unique tumour which is endemic in Southern China including Hong Kong. While the treatment results for early disease are encouraging, patients with advanced cancer are uniformly associated with poor prognosis. Epstein-Barr virus (EBV), the first virus related to the development of human malignancy, plays an important role in the carcinogenesis of the disease. ...
متن کاملStroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment.
BACKGROUND Stroke is a devastating condition encompassing a wide range of pathophysiological entities that include thrombosis, hemorrhage, and embolism. Current diagnosis of stroke relies on physician clinical examination and is further supplemented with various neuroimaging techniques. A single set or multiple sets of blood biomarkers that could be used in an acute setting to diagnosis stroke,...
متن کاملNovel Biomarkers in Determining Prostate Cancer Diagnosis and Prognosis
Corresponding Author: Zuzana Varchulova Novakova Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovakia E-mail: [email protected] Abstract: The clinical behavior and molecular pathology of prostate cancer is highly variable. Current “traditional” prognostic markers cannot reliably distinguish the potentially lif...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomarkers in Medicine
سال: 2009
ISSN: 1752-0363,1752-0371
DOI: 10.2217/bmm.09.30